Onward Medical N.V. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 0.9 million compared to EUR 1 million a year ago. Net loss was EUR 19.2 million compared to EUR 16 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 EUR | -2.27% | -2.87% | +52.58% |
25/04 | Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02/04 | Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+52.58% | 176M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
-32.61% | 2.54B | |
-0.74% | 1.99B | |
+10.80% | 1.99B |
- Stock Market
- Equities
- ONWD Stock
- News Onward Medical N.V.
- Onward Medical N.V. Reports Earnings Results for the Half Year Ended June 30, 2023